Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $13.64 and last traded at $13.59, with a volume of 224624 shares trading hands. The stock had previously closed at $13.40.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on RBGLY shares. Barclays downgraded shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, February 4th. HSBC raised shares of Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research note on Wednesday, December 11th. Finally, Hsbc Global Res raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a report on Wednesday, December 11th. Three research analysts have rated the stock with a hold rating, one has issued a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy".
View Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Up 3.4 %
The stock's fifty day moving average is $12.82 and its two-hundred day moving average is $12.39. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
